Xbrane Biopharma AB (XBRANE) — Cash Flow Reinvestment Rate
Xbrane Biopharma AB (XBRANE) has a Cash Flow Reinvestment Rate of 0.37x as of December 2024, reinvesting Skr34.60 Million (capex Skr17.30 Million plus investments Skr-17.30 Million) from operating cash flow of Skr93.91 Million. Explore XBRANE capex to operating cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Xbrane Biopharma AB Cash Flow Reinvestment Rate (2018–2018)
Historical reinvestment intensity for Xbrane Biopharma AB across 1 annual periods. Also explore total assets of Xbrane Biopharma AB for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Xbrane Biopharma AB (2018–2018)
Year-by-year capital reinvestment analysis for Xbrane Biopharma AB. For live market cap and broader valuation context, see Xbrane Biopharma AB (XBRANE) total market value.
| Year | Reinvestment Rate | Total Reinvested (SEK) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2018 | 0.07x | Skr3.20 Million | Skr46.71 Million | Skr1.60 Million | — |